Robert J Harris

Title: Robert J Harris: Innovator in Pharmaceutical Compositions

Introduction

Robert J Harris is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug efficacy. His work is characterized by a focus on improving treatment options for various disorders.

Latest Patents

Harris holds a patent for "Pralsetinib pharmaceutical compositions." This patent describes a pharmaceutical composition that includes an amorphous solid dispersion comprising pralsetinib, or a pharmaceutically acceptable salt thereof, along with a hydrophilic polymer and an effervescent couple. The patent also covers crystalline forms of pralsetinib and pralsetinib hydrochloride salt, which serve as selective inhibitors for RET. These compositions are designed to improve the treatment of various medical conditions.

Career Highlights

Harris is associated with Rigel Pharmaceuticals, Incorporated, where he has been instrumental in advancing pharmaceutical research and development. His expertise in creating effective drug formulations has positioned him as a key player in the industry. With 1 patent to his name, he continues to contribute to the field of medicine through innovative solutions.

Collaborations

Throughout his career, Harris has collaborated with talented professionals, including Kimberly Jean Miller and Debra L Mazaik. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical science.

Conclusion

Robert J Harris exemplifies the spirit of innovation in the pharmaceutical industry. His work on pralsetinib compositions showcases his commitment to improving healthcare outcomes. Through his contributions, he continues to make a lasting impact on the field of medicine.